CooperCompanies Announces First Quarter 2025 Results

Core Insights - CooperCompanies reported a fiscal first quarter revenue of $964.7 million, representing a 4% year-over-year increase [4] - The company achieved a GAAP diluted earnings per share (EPS) of $0.52, up from $0.41 in the previous year [39] - Non-GAAP diluted EPS increased to $0.92, compared to $0.85 in the same quarter last year [39] Financial Performance - CooperVision (CVI) revenue was $646.1 million, up 4% year-over-year, with organic growth of 6% [4][41] - CooperSurgical (CSI) revenue reached $318.6 million, a 3% increase from the previous year, with organic growth of 2% [10][41] - Gross margin improved to 68%, up from 67% in the prior year, driven by efficiency gains [4] Geographic Revenue Breakdown - Revenue from the Americas was $270.9 million, reflecting a 7% increase year-over-year [3] - EMEA revenue was $246.5 million, up 3% year-over-year [3] - Asia Pacific revenue decreased by 2% to $128.7 million [3] Guidance and Future Outlook - The company raised its fiscal year 2025 total revenue guidance to between $4,080 million and $4,158 million, with organic growth projected at 6% to 8% [11] - Non-GAAP diluted EPS guidance for fiscal 2025 is set between $3.94 and $4.02, an increase from previous guidance [11] Cash Flow and Expenses - Cash provided by operations was $190.6 million, leading to a free cash flow of $101.2 million after capital expenditures of $89.4 million [4] - Interest expense decreased to $26.0 million from $29.9 million in the previous year due to lower interest rates [4]